Skip to main content
SpringerLink
Log in

Drug Interactions with Valproic Acid

  • Review Articles
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Valproic acid undergoes drug-drug interactions with most of the commonly used anti-convulsants. Since it possesses a wide range of indications, concomitant use with other anticonvulsants, and hence interactions, are not infrequent. Many of these interactions are reciprocal and may have important therapeutic consequences.

Valproate acts as a protein binding displacer and/or metabolic inhibitor with respect to a number of other anticonvulsants (phenobarbitone, primidone, phenytoin). Inhibition of metabolism would, in most instances, result in a decrease of the dose requirements of the affected drugs.

Valproate is a low clearance drug primarily eliminated by metabolism. Its metabolism is highly inducible by some of the major anticonvulsants (e.g. carbamazepine, phenytoin). Valproate is also highly protein bound in plasma and thus is displaced by salicylates and free fatty acids. However, displacement alone, unlike induced metabolism, should not affect the drug’s dose-response relationship.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adams, D.J.; Luders, H. and Pippenger, G: Sodium valproate in the treatment of intractable seizure disorders: a clinical and electroencephalographic study. Neurology 28: 152–157 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Bardy, A.; Hari, R.; Lehtovaara, R. and Majuri, H.: Valproate may lower serum phenytoin. Lancet 1: 1256–1257 (1976).

    Google Scholar 

  • Barnes, S.E. and Bower, B.D.: Sodium valproate in the treatment of intractable childhood epilepsy. Developmental Medicine and Child Neurology 17: 175–181 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Bauer, L.A.; Harris, G.; Wilensky, A.J.; Raisys, V. and Levy, R.H.: Ethosuximide Kinetics: Possible interaction with valproic acid. Clinical Pharmacology and Therapeutics 31(6): 741–745 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Bowdle, T.A.; Levy, R.H. and Cutler, R.E.: Effects of carbamazepine on valproic acid kinetics in normal subjects. Clinical Pharmacology and Theapeutics 26: 629–634 (1979).

    CAS  Google Scholar 

  • Bowdle, T.A.; Patel, I.H.; Levy, R.H. and Wilensky, A.J.: The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humans. European Journal of Clinical Pharmacology (In press, 1982).

  • Bruni, J.; Gallo, J.M.; Lee, C.S.; Perchalski, R.J. and Wilder, B.J.: Interactions of valproic acid with phenytoin. Neurology 30: 1233–1236 (1980a).

    Article  PubMed  CAS  Google Scholar 

  • Bruni, J.; Wilder, B.J.; Perchalski, R.J.; Hammond, E.J. and Villarreal, H.J.: Valproic acid and plasma levels of phenobarbital. Neurology 30: 94–97 (1980b).

    Article  PubMed  CAS  Google Scholar 

  • Bruni, J.; Wilder, B.J.; Willmore, I.J. and Barbour, B.: Valproic acid and plasma levels of serum phenytoin. Neurology 29: 904–905 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Coulthard, M.G.: Sodium valproate in the treatment of intractable childhood epilepsy. Developmental Medicine and Child Neurology 17: 534 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Cramer, J.A. and Mattson, R.H.: Valproic acid: in vitro plasma protein binding and interactions with phenytoin. Therapeutic Drug Monitoring 1: 105–116 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Dahlqvist, R.; Borga, O.; Rane, A.; Walsh, Z. and Sjoqvist, F.: Decreased plasma protein binding of phenytoin in patients on valproic acid. British Journal of Clinical Pharmacology 8: 547–552 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Farrell, K.; Orr, J.M.; Abbott, F.S.; Ferguson, S.; Sheppard, I.; Godolphin, W. and Brum, J.: The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in children. Journal of Pediatrics 101: 142–144 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Fisher, J.H.; Cloyd, J.C.; Kriel, R.L.; Eggreth, R. and Sawchuck, R.J.: The effect of concomitant antiepileptic therapy on valproic acid pharmacokinetics. Epilepsia (In press, 1982).

  • Flachs, H.; Gram, L.; Würtz-Jørgensen, A. and Parnes, J.: Drug levels of other antiepileptic drugs during concomitant treatment with sodium valproate. Epilepsia 20: 187 (1979).

    Google Scholar 

  • Fleitman, J.S.; Bruni, J.; Perrin, J.H. and Wilder, B.J.: Albumin binding interactions of sodium valproate. Journal of Clinical Pharmacology 20: 314–317 (1980).

    Google Scholar 

  • Friel, P.N.; Leal, K.W. and Wilensky, A.J.: Valproic acid-phenytoin interaction. Therapeutic Drug Monitoring 1: 243–248 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Frigo, G.M.; Lecchini, S.; Gatti, G.; Perucca, E. and Crema, A.: Modification of phenytoin clearance by valproic acid in normal subjects. British Journal of Clinical Pharmacology 8: 553–556 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Gram, L.; Wulff, K.; Rasmussen, K.E.; Flachs, H.; Würtz-Jørgensen, A.; Sommerbeck, K.W. and Lohren, V.: Valproate sodium: a controlled clinical trial including monitoring of drug levels. Epilepsia 18: 141–148 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Gugler, R. and von Unruh, G.E.: Clinical pharmacokinetics of valproic acid. Clinical Pharmacokinetics 5: 67–83 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Harwood, G. and Harvey, P.K.P.: Results of a clinical trial on the use of Epilim in convulsive disorders, with special reference to its efficacy in temporal lobe attacks with focal features; in Legg (Ed.) Clinical and Pharmacological Aspects of Sodium Valproate (’Epilim’) in the Treatment of Epilepsy, pp.40–43 (MCS Consultants, Tunbridge Wells 1976).

    Google Scholar 

  • Hassan, M.N.; Laljee, H.C.K. and Parsonage, M.J.: Sodium valproate in the treatment of resistant epilepsy. Acta Neurologica Scandinavica 54: 209–218 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Henricksen, O. and Johannessen, S.I.: Clinical observations of sodium valproate in children: an evaluation of therapeutic serum levels; in Johannessen et al. (Eds.) Antiepileptic Therapy: Advances in Drug Monitoring, pp.253–261 (Raven Press, New York 1980).

    Google Scholar 

  • Hoffman, F.; von Unruh, G.E. and Jancik, B.C.: Valproic acid disposition in epileptic patients during combined antiepileptic maintenance therapy. European Journal of Clinical Pharmacology 19: 383–385 (1981).

    Article  Google Scholar 

  • Huang, M.-Y.; Johno, I. and Levy, R.H.: Systemic interaction between valproic acid and free fatty acids in rhesus monkeys. Abstract No. 64, Proceedings of the American Pharmaceutical Association Meeting, St Louis (April, 1981).

  • Jeavons, P.M. and Clark, J.E.: Sodium valproate in treatment of epilepsy. British Medical Journal 2: 584–586 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Jeavons, P.M.; Clark, J.E. and Maheswari, M.C.: Treatment of generalized epilepsies of childhood and adolescence with sodium valproate (’Epilim’). Developmental Medicine and Child Neurology 19: 9–25 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Johannessen, S.I. and Henriksen, O.: Pharmacokinetic observations of sodium valproate in healthy subjects and patients with epilepsy; in Johannessen et al. (Eds) Antiepileptic Therapy: Advances in Drug Monitoring, pp.131–141 (Raven Press, New York 1980).

    Google Scholar 

  • Jordan, B.J.; Shillingford, J.S. and Steed, K.P.: Preliminary observations on the protein binding and enzyme-inducing properties of sodium valproate (’Epilim’); in Legg (Ed.) Clinical and Pharmacological Aspects of Sodium Valproate (’Epilim’) in the Treatment of Epilepsy, pp. 112–116 (MCS Consultants, Tunbridge Wells 1976).

    Google Scholar 

  • Kapetanovic, I.M. and Kupferberg, H.J.: Inhibition of microsomal phenobarbital metabolism by valproic acid. Federation Proceedings 39: 1099(1980).

    Google Scholar 

  • Kapetanovic, I.; Kupferberg, H.J.; Porter, R.J. and Penry, J.K.: Valproic acid-phenobarbital interaction: a systematic study using stable isotopically labelled phenobarbital in an epileptic patient; in Johannessen et al. (Eds) Antiepileptic Therapy: Advances in Drug Monitoring, pp.373–380 (Raven Press, New York 1980).

  • Kapetanovic, I.M.; Kupferberg, H.J.; Porter, R.J.; Theodore, W.; Schulman, E. and Penry, J.K.: Mechanism of valproatephenobarbital interaction in epileptic patients. Clinical Pharmacology and Therapeutics 29: 480–486 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Knott, C.; Hamshaw-Thomas, A. and Reynolds, F.: Phenytoinvalproate interaction: Importance of saliva monitoring in epilepsy. British Medical Journal 284: 13–17 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Kober, A.; Olsson, Y. and Sjoholm, I.: Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate. Molecular Pharmacology 18: 237–242 (1980).

    PubMed  CAS  Google Scholar 

  • Koch, K.M.; Ludwick, B.T. and Levy, R.H.: Phenytoin-valproic acid interaction in rhesus monkey. Epilepsia 22: 19–25 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Lehtovaara, R.; Bardy, A.; Hari, R. and Majuri, H.: Sodium valproate and clonazepam interactions with phenytoin and carbamazepine; in Meinardi and Rowan (Eds) Advances in Epileptology —1977, pp.269–270 (Swets and Zeitlinger, Amsterdam 1978).

    Google Scholar 

  • Levy, R.H.: Monitoring of free valproic acid levels? Therapeutic Drug Monitoring 2: 199–201 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Lockard, J.S. and Levy, R.H.: Multilevel interactions of valproate and phenytoin in alumina-gel monkeys. Epilepsia 22: 229 (1981).

    Google Scholar 

  • Loiseau, P.; Brachet, A. and Henry, P.: Étude du taux serique du phenobarbital chez des epileptiques. L’Encephale 1: 341–357 (1975).

    PubMed  CAS  Google Scholar 

  • Loiseau, P.; Orgogozo, J.M.; Brachet-Liermain, A. and Morselli, P.L.: Pharmacokinetic studies on the interaction between phenobarbital and valproic acid; in Meinardi and Rowan (Eds) Advances in Epileptology —1977, pp.261–265 (Swets and Zeitlinger, Amsterdam 1978).

    Google Scholar 

  • Loiseau, P.; Orgogozo, J.M.; Cenraud, B. and Brachet-Liermain, A.: Further pharmacokinetic observations on the interaction between phenobarbital and valproic acid in epileptic patients; in Wada and Penry (Eds) Advances in Epileptology: The 10th International Symposium, pp.353–354 (Raven Press, New York 1980).

    Google Scholar 

  • Mattson, R.H. and Cramer, J.A.: Valproic acid and ethosuximide interaction. Annals of Neurology 7: 583–584 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Mattson, R.H.; Cramer, J.A.; Williamson, P.D. and Novelly, R.: Valproic acid in epilepsy: clinical and pharmacological effects. Annals of Neurology 3: 20–25 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Mattson, G.F.; Mattson, R.H. and Cramer, J.A.: Valproic acid interaction with carbamazepine. Annals of Neurology 8: 127 (1980).

    Google Scholar 

  • Mesdjian, E.; Mesdjian, J.L.; Bouyard, P.; Dravet, C. and Roger, J.: Effect of sodium valproate on phenobarbitone plasma levels in epileptic patients; in Meinardi and Rowan (Eds) Advances in Epileptology —1977, pp.266–268 (Swets and Zeitlinger, Amsterdam 1978).

    Google Scholar 

  • Mihaly, G.W.; Vajda, F.J.; Miles, J.L. and Louis, W.J.: Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients. European Journal of Pharmacology 15: 23–29 (1979).

    Google Scholar 

  • Monks, A.; Boobis, S.; Wadsworth, J. and Richens, A.: Plasma protein binding interaction between phenytoin and valproic acid in vitro. British Journal of Clinical Pharmacology 6: 487–492 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Monks, A. and Richens, A.: Serum protein binding of valproic acid and its displacement by palmitic acid in vitro. British Journal of Clinical Pharmacology 8: 187–188 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Monks, A. and Richens, A.: Effect of single dose of sodium valproate on serum phenytoin concentration and protein binding in epileptic patients. Clinical Pharmacology and Therapeutics 27: 89–95 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Mortensen, P.B.: Inhibition of fatty acid oxidation by valproate. Lancet 2: 856–857 (1980).

    PubMed  CAS  Google Scholar 

  • Orr, J.M.; Abbott, F.S.; Farrell, K.; Ferguson, S.; Sheppard, I. and Godolphin, W.: Interaction between valproic acid and aspirin in epileptic children: Serum protein binding and metabolic effects. Clinical Pharmacology and Therapeutics 31(5): 642–649 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Oxley, J.; Hedges, A.; Makki, K.A.; Monks, A. and Richens, A.: Lack of hepatic enzyme inducing effect of sodium valproate. British Journal of Clinical Pharmacology 8: 189–190 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Patel, I.H. and Levy, R.H.: Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids. Epilepsia 20: 85–90 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Patel, I.H.; Levy, R.H. and Cutler, R.E.: Phenobarbital-valproic acid interaction in normal man. Clinical Pharmacology and Therapeutics 27: 515–521 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Patsalos, P.N. and Lascelles, P.T.: Effect of sodium valproate on plasma protein binding of diphenylhydantoin. Journal of Neurology, Neurosurgery and Psychiatry 50: 570–574 (1977a).

    Article  Google Scholar 

  • Patsalos, P.N. and Lascelles, P.T.: In vitro hydroxylation of diphenylhydantoin and its inhibition by other commonly used anticonvulsant drugs. Biochemical Pharmacology 26: 1929–1933 (1977b).

    Article  PubMed  CAS  Google Scholar 

  • Patsalos, P.N. and Lascelles, P.T.: Diphenylhydantoin substrate induced difference spectra: inhibition by other anticonvulsant drugs. Research Communications in Chemical Pathology and Pharmacology 27: 31–43 (1980).

    PubMed  CAS  Google Scholar 

  • Perucca, E.; Gatti, G.; Frigo, G.M.; Crema, A.; Calzetti, S.; and Visintini, D.: Sodium valproate in epileptic patients. British Journal of Pharmacology 5: 495–499 (1978).

    Article  CAS  Google Scholar 

  • Perucca, E.; Hebdige, S.; Frigo, G.M.; Gatti, G.; Lecchini, S. and Crema, A.: Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects. Clinical Pharmacology and Therapeutics 28: 779–789 ( 1980).

    Article  PubMed  CAS  Google Scholar 

  • Pisani, F.D. and Di Perri, R.G.: Intravenous valproate: Effects on plasma and saliva phenytoin levels. Neurology 31(4): 467–470 (1981)

    Article  PubMed  CAS  Google Scholar 

  • Potolicchio, S.J., Jr: L’efficacité du di-n-prophylacetate de sodium (’Depakine’) en monotherapie dans les absences simples et complexes. Thesis Medécine, Universitie Geneve (1977).

  • Redenbaugh, J.E.; Sato, S.; Penry, J.K.; Dreifuss, F.E. and Kupferberg, H.J.: Sodium valproate: pharmacokinetics and effectiveness in treating intractable seizures. Neurology 30: 1–6 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Reunanen, M.I.; Luoma, P.; Myllyla, V.V. and Hokkanen, E.: Low serum valproic acid concentrations in epileptic patients on combination therapy. Current Therapeutic Research 28: 455–462 (1980).

    Google Scholar 

  • Richens, A. and Ahmad, S.: Controlled trial of sodium valproate in severe epilepsy. British Medical Journal 4: 255–256 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Richens, A.; Scoular, I.T.; Ahmad, S. and Jordan, B.J.: Pharmacokinetics and efficacy of Epilim in patients receiving long-term therapy with other antiepileptic drugs; in Legg (Ed.) Clinical and Pharmacological Aspects of Sodium Valproate (’Epilim’) in the Treatment of Epilepsy, pp.78–88 (MCS Consultants, Tunbridge Wells 1976).

    Google Scholar 

  • Rodin, E.A.; De Sousa, G.; Haidukewych, D.; Lodhi, R. and Berchou, R.C.: Dissociation between free and bound phenytoin levels in presence of valproate sodium. Archives of Neurology 38(4): 240–242 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Rowan, A.J.; Meijer, J.W.A.; Binnie, CD.; deBeer-Pawlikowski, N.; Gutter, T.; Goedhart, D.; van der Geest, P. and Meinardi, H.: Sodium valproate and sodium valproate-ethosuximide combination therapy: intensive monitoring studies; in Johannessen et al. (Eds) Antiepileptic Therapy: Advances in Drug Monitoring, pp.161–168 (Raven Press, New York 1980).

    Google Scholar 

  • Sackellares, J.C.; Lee, S.I. and Dreifuss, F.E.: Stupor following administration of valproic acid to patients receiving other antiepileptic drugs. Epilepsia 20: 697–703 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Sackellares, J.C.; Sato, S.; Dreifuss, F.E. and Perry, J.K.: Reduction of steady-state valproate levels by other antiepileptic drugs. Epilepsia 22: 437–441 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Sapeika, N. and Kaplan, E.R.: Effect of the antiepileptic drug sodium valproate on induction of hepatic microsomal P450. Research Communications in Chemical Pathology and Pharmacology 10: 767–769 (1975).

    PubMed  CAS  Google Scholar 

  • Schobben, F.; van der Kleijn, E. and Gabreels, F.J.M.: Pharmacokinetics of di-N-propylacetate in epileptic patients. European Journal of Clinical Pharmacology 8: 97–105 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Schobben, F.; Vree, T.B. and van der Kleijn, E.: Pharmacokinetics, metabolism and distribution of 2-N-propyl pentanoate (sodium valproate) and the influence of salicylate comedication; in Meinardi and Rowan (Eds) Advances in Epileptology-1977, pp.271–277 (Swets and Zeitlinger, Amsterdam 1978).

    Google Scholar 

  • Suganuma, T.; Ishizaki, T.; Chiba, K. and Hori, M.: The effect of concurrent administration of valproate sodium on phenobarbital plasma concentration/dosage ratio in pediatric patients. Journal of Pediatrics 99(2): 314–317 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Urien, S.: Fixation de l’acide valproique et de sonamide sur les proteines du serum consequence pharmacologiques et therapeutiques. Ph.D. Thesis, University of Paris, Val-de-Marme, France (1979).

  • Vajda, F.J.; Morris, P.; Drummer, O. and Bladin, P.: Studies on sodium valproate — a new anticonvulsant; in Legg (Ed.) Clinical and Pharmacological Aspects of Sodium Valproate (’Epilim’) in the treatment of Epilepsy, pp.92–100 (MSC Consultants, Tunbridge Wells 1976).

    Google Scholar 

  • Vakil, S.D.; Critchley, E.M.R.; Philips, J.C.; Haydock, C.; Cocks, A. and Dyer, T.: The effect of sodium valproate (’Epilim’) on phenytoin and phenobarbitone blood levels; in Legg (Ed.) Clinical and Pharmacological Aspects of Sodium Valproate (’Epilim’) in the Treatment of Epilepsy, pp.75–77 (MCS Consultants, Tunbridge Wells 1976).

    Google Scholar 

  • Varma, R. and Hoshimo, A.: Simultaneous gas-chromatographic measurement of valproic acid in psychiatric patients: effect on levels of other simultaneously administered anticonvulsants. Neuroscience Letters 11: 353–356 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Viswanathan, C.T. and Levy, R.H.: Plasma protein binding interaction between valproic and salicylic acids in rhesus monkeys. Journal of Pharmaceutical Sciences 70: 1279–1281 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Voelzke, E. and Doose, H.: Dipropylacetate (’Depakine’, ‘Ergenyl’) in the treatment of epilepsy. Epilepsia 14: 185–193 (1973).

    Article  Google Scholar 

  • Wilder, B.J.; Willmore, I.J.; Bruni, J. and Villareal, HJ.: Valproic acid: interaction with other anticonvulsant drugs. Neurology 28: 892–896 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Windorfer, A. and Sauer, W.: Drug interactions during anticonvulsant therapy in childhood: diphenylhydantoin, primidone, phenobarbitone, clonazepam, nitrazepam, carbamazepine, and dipropylacetate. Neuropaediatrie 8: 29–41 (1977).

    Article  Google Scholar 

  • Windorfer, A.; Sauer, W. and Gadeke, R.: Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug. Acta Paediatrica Scandinavica 64: 771–772 (1975).

    Article  PubMed  Google Scholar 

  • Zimmerman, C.L.; Patel, I.H.; Levy, R.H.; Edwards, D.; Nelson, S.D. and Hutchinson, M.: Protein binding of valproic acid in the presence of elevated free fatty acids in patient and normal human serum. Epilepsia 22: 11–17 (1981).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, BG-20, University of Washington, Seattle, Wash., 98195, USA

    René H. Levy & Kevin M. Koch

Authors
  1. René H. Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kevin M. Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levy, R.H., Koch, K.M. Drug Interactions with Valproic Acid. Drugs 24, 543–556 (1982). https://doi.org/10.2165/00003495-198224060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198224060-00004

Keywords

Search

Navigation